{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:51:36Z","timestamp":1789383096258,"version":"build-2803163510"},"publisher-location":"Chichester, UK","reference-count":75,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd008452.pub3","type":"reference-entry","created":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T00:01:01Z","timestamp":1367107261000},"source":"Crossref","is-referenced-by-count":26,"title":["Hormonal contraceptives for contraception in overweight or obese women"],"prefix":"10.1002","author":[{"given":"Laureen M","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Otterness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans M","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD008452.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.contraception.2008.12.013","article-title":"Association between efficacy and body weight or body mass index for two low-dose oral contraceptives","volume":"79","author":"Burkman","year":"2009","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0010-7824(01)00214-1","article-title":"Comparison of a novel norgestimate\/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1\/20","volume":"63","author":"Hampton","year":"2001","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.contraception.2008.02.007","article-title":"Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives","volume":"77","author":"Hampton","year":"2008","journal-title":"Contraception"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD008452.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1097\/00006250-200604001-00117","article-title":"Higher body weight and body mass index are not associated with reduced efficacy in Ortho Tri-Cyclen Lo users (abstract)","volume":"107","author":"Zhang","year":"2006","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0010-7824(00)10782-N","article-title":"Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience","volume":"52","author":"Grubb","year":"1995","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0010-7824(95)00141-7","article-title":"Effectiveness of Norplant implants through seven years: a large-scale study in China","volume":"52","author":"Gu","year":"1995","journal-title":"Contraception"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD008452.pub3-BIB7|cit7","first-page":"673","article-title":"A 5-year evaluation of NORPLANT contraceptive implants in China","volume":"83","author":"Gu","year":"1994","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD008452.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(96)00276-4","article-title":"Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0010-7824(01)00226-8","article-title":"Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants","volume":"64","author":"Sivin","year":"2001","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2009.07.003","article-title":"The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol","volume":"81","author":"Kroll","year":"2010","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub3-BIB12|cit12","doi-asserted-by":"crossref","unstructured":"Westhoff CL Hait HI Reape KZ Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive Contraception 2012 235 9","DOI":"10.1016\/j.contraception.2011.08.001"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0010-7824(90)90141-H","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects","volume":"41","year":"1990","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0010-7824(90)90142-I","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals","volume":"41","year":"1990","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(90)90143-J","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization","volume":"41","year":"1990","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub3-BIB16|cit16","doi-asserted-by":"crossref","unstructured":"Secura GM Allsworth JE Madden T Mullersman JL Peipert JF The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception American Journal of Obstetrics and Gynecology 2010 115 e1-7","DOI":"10.1016\/j.ajog.2010.04.017"},{"key":"10.1002\/14651858.CD008452.pub3-BIB17|cit17","doi-asserted-by":"crossref","unstructured":"Xu H Wade JA Peipert JF Zhao Q Madden T Secura GM Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women Obstetrics and Gynecology 2012 21 6","DOI":"10.1097\/AOG.0b013e318259565a"},{"issue":"18","key":"10.1002\/14651858.CD008452.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"Journal of the American Medical Association"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD008452.pub3-BIB19|cit19","first-page":"799","article-title":"Efficacy and safety of a transdermal contraceptive system","volume":"98","author":"Smallwood","year":"2001","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception","volume":"121","author":"Urdl","year":"2005","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD008452.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008452.pub3-BIB22|cit22","doi-asserted-by":"crossref","unstructured":"Banerjee SK Baweja R Bhatt RV Chatterjee A Choudhury SD Coyaji B Comparative evaluation of contraceptive efficacy of norethisterone oenanthate (200 mg) injectable contraceptive given every two or three monthly. Indian Council of Medical Research Task Force on Hormonal Contraception Contraception 1984 561 74","DOI":"10.1016\/0010-7824(84)90006-4"},{"key":"10.1002\/14651858.CD008452.pub3-BIB23|cit23","doi-asserted-by":"crossref","unstructured":"Berenson AB van den Berg P Williams KJ Rahman M Effect of injectable and oral contraceptives on glucose and insulin levels Obstet Gynecol 2011 41 7","DOI":"10.1097\/AOG.0b013e318202ac23"},{"key":"10.1002\/14651858.CD008452.pub3-BIB24|cit24","doi-asserted-by":"crossref","unstructured":"Casey PM Long ME Marnach ML Bury JE Bleeding related to etonogestrel subdermal implant in a US population Contraception 2011 426 30","DOI":"10.1016\/j.contraception.2010.09.012"},{"issue":"12","key":"10.1002\/14651858.CD008452.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1055\/s-2008-1026401","article-title":"[Incidence of side effects caused by a three-stage preparation administered to 10,034 women]","volume":"50","author":"Cirkel","year":"1991","journal-title":"Geburtshilfe und Frauenheilkunde"},{"key":"10.1002\/14651858.CD008452.pub3-BIB26|cit26","doi-asserted-by":"crossref","unstructured":"Du MK Chow LP Zheng HM Chen CH A 10-year follow-up study of contraceptive Norplant implants International Journal of Gynaecology & Obstetrics 2000 249 56","DOI":"10.1016\/S0020-7292(99)00214-3"},{"key":"10.1002\/14651858.CD008452.pub3-BIB27|cit27","doi-asserted-by":"crossref","unstructured":"Du MK Zheng HM Chen HC Chow LP Study of Norplant implants in Shanghai: three-year experience International Journal of Gynaecology & Obstetrics 1990 345 57","DOI":"10.1016\/0020-7292(90)90521-L"},{"key":"10.1002\/14651858.CD008452.pub3-BIB28|cit28","doi-asserted-by":"crossref","unstructured":"Glasier A Cameron ST Blithe D Scherrer B Mathe H Levy D Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel Contraception 2011 363 7","DOI":"10.1016\/j.contraception.2011.02.009"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008452.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13625180801942754","article-title":"The contraceptive efficacy of Implanon\u00ae: a review of clinical trials and marketing experience","volume":"13","author":"Graesslin","year":"2008","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD008452.pub3-BIB30|cit30","doi-asserted-by":"crossref","unstructured":"Moreau C Trussell J Results from pooled Phase III studies of ulipristal acetate for emergency contraception Contraception 2012","DOI":"10.1016\/j.contraception.2012.05.012"},{"key":"10.1002\/14651858.CD008452.pub3-BIB31|cit31","unstructured":"Mornar S Chan L-N Mistretta S Neustadt A Martins S Gilliam M Pharmacokinetics of the etonogestrel contraceptive implant in obese women American Journal of Obstetrics and Gynecology e1 6"},{"key":"10.1002\/14651858.CD008452.pub3-BIB32|cit32","unstructured":"Neustadt A Gilliam M Pharmacokinetics of Implanon in obese women http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00724438"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2307\/1966493","article-title":"International experience with NORPLANT\u00ae and NORPLANT\u00ae-2 contraceptives","volume":"19","author":"Sivin","year":"1988","journal-title":"Studies in Family Planning"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0010-7824(96)00275-2","article-title":"Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub3-BIB35|cit35","doi-asserted-by":"crossref","unstructured":"Sivin I Mishell DR Diaz S Biswas A Alvarez F Darney P Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study Contraception 2000 187 94","DOI":"10.1016\/S0010-7824(00)00095-0"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0010-7824(99)00035-9","article-title":"Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring","volume":"59","author":"Weisberg","year":"1999","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.contraception.2012.04.035","article-title":"Increased compliance with a low-dose combination contraceptive patch (AG200-15) compared with a low-dose combination oral contraceptive (COC) in a Phase 3 clinical trial (abstract)","volume":"86","author":"Kaunitz","year":"2012","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.contraception.2012.05.106","article-title":"Increased compliance independent of patient demographics with a low-dose combination contraceptive patch (AG200-15) compared with a low-dose combination oral contraceptive in a Phase 3 clinical trial (abstract)","volume":"86","author":"Kaunitz","year":"2012","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub3-BIB39|cit39","unstructured":"Kaunitz AM Mishell DR Foegh M Comparative Phase 3 study of AG200-15, a low-dose estrogen and levonorgestrel contraceptive patch http:\/\/www.agiletherapeutics.com\/Clinical_support.html"},{"issue":"4","key":"10.1002\/14651858.CD008452.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD008452.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annepidem.2006.01.001","article-title":"Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina","volume":"16","author":"Brunner Huber","year":"2006","journal-title":"Annals of Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD008452.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2004.10.009","article-title":"The role of body weight in oral contraceptive failure: results from the 1995 National Survey of Family Growth","volume":"15","author":"Brunner","year":"2005","journal-title":"Annals of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD008452.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/aje\/kwm221","article-title":"Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth","volume":"166","author":"Brunner Huber","year":"2007","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD008452.pub3-BIB44|cit44","unstructured":"Centers for Disease Control and Prevention Defining Overweight and Obesity http:\/\/www.cdc.gov\/obesity\/adult\/defining.html"},{"key":"10.1002\/14651858.CD008452.pub3-BIB45|cit45","unstructured":"CONSORT group CONSORT: Transparent reporting of trials http:\/\/www.consort-statement.org\/"},{"issue":"3","key":"10.1002\/14651858.CD008452.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"263.e1","DOI":"10.1016\/j.ajog.2009.03.017","article-title":"Oral contraceptive effectiveness according to body mass index, weight, age, and other factors","volume":"201","author":"Dinger","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008452.pub3-BIB47|cit47","doi-asserted-by":"crossref","unstructured":"Dinger J Minh TD Buttmann N Bardenheuer K Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen Obstetrics and Gynecology 2011 33 40","DOI":"10.1097\/AOG.0b013e31820095a2"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.contraception.2009.08.001","article-title":"Contraceptive considerations in obese women","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD008452.pub3-BIB51|cit51","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003987.pub4","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2005.04.002","article-title":"Family planning for obese women: challenges and opportunities","volume":"72","author":"Grimes","year":"2005","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub3-BIB53|cit53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007541.pub2","article-title":"Progestin-only pills for contraception","author":"Grimes","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.fertnstert.2009.12.054","article-title":"Surrogate end points in women's health research: science, protoscience, and pseudoscience","volume":"93","author":"Grimes","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD008452.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008452.pub3-BIB56|cit56","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD008452.pub3-BIB57|cit57","first-page":"820","article-title":"Body weight and risk of oral contraceptive failure","volume":"99","author":"Holt","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.AOG.0000149155.11912.52","article-title":"Body mass index, weight, and oral contraceptive failure risk","volume":"105","author":"Holt","year":"2005","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD008452.pub3-BIB59|cit59","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006133.pub4","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","author":"Lopez","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008452.pub3-BIB60|cit60","article-title":"Obesity among adults in the United States- no change since 2003-2004","volume-title":"NCHS data brief no 1","author":"Ogden","year":"2007"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ije\/dyi272","article-title":"The emerging epidemic of obesity in developing countries","volume":"35","author":"Prentice","year":"2006","journal-title":"International Journal of Epidemiology"},{"issue":"9306","key":"10.1002\/14651858.CD008452.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD008452.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2010.01.021","article-title":"Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously","volume":"81","author":"Segall-Gutierrez","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0010-7824(01)00226-8","article-title":"Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants","volume":"64","author":"Sivin","year":"2001","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub3-BIB65|cit65","volume-title":"Evidence-based Medicine: How to Practice and Teach EBM","author":"Strauss","year":"2005"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.contraception.2008.11.017","article-title":"Obesity and oral contraceptive pill failure","volume":"79","author":"Trussell","year":"2009","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub3-BIB67|cit67","unstructured":"United Nations Department of Economic and Social Affairs Population Division World Contraceptive Use 2011 http:\/\/www.un.org\/esa\/population\/publications\/contraceptive2011\/contraceptive2011.htm"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1783\/147118901101195092","article-title":"Oral contraceptive failures and body weight: findings in a large cohort study","volume":"27","author":"Vessey","year":"2001","journal-title":"Journal of Family Planning and Reproductive Health Care"},{"key":"10.1002\/14651858.CD008452.pub3-BIB69|cit69","unstructured":"GA Wells Shea B O'Connell D Peterson J Welch V Losos M Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD008452.pub3-BIB70|cit70","first-page":"56S","article-title":"Higher body weight does not affect NuvaRing's efficacy (abstract)","volume":"105","author":"Westhoff","year":"2005","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.contraception.2008.04.009","article-title":"Subject weight and oral contraceptive efficacy in recent clinical trials (abstract)","volume":"78","author":"Westhoff","year":"2008","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD008452.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.contraception.2009.05.061","article-title":"Ovarian suppression during oral contraceptive use in normal-weight and obese women","volume":"80","author":"Westhoff","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008452.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"39.e1","DOI":"10.1016\/j.ajog.2012.04.022","article-title":"Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women","volume":"207","author":"Westhoff","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD008452.pub3-BIB74|cit74","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.09.019","article-title":"Predictors of noncompliance in an oral contraceptive clinical trial","volume":"85","author":"Westhoff","year":"2012","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD008452.pub3-BIB75|cit75","unstructured":"World Health Organization Obesity http:\/\/www.euro.who.int\/en\/what-we-do\/health-topics\/noncommunicable-diseases\/obesity"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008452.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008452.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:20:26Z","timestamp":1628533226000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008452.pub3"}},"subtitle":[],"editor":[{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":75,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008452.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD008452.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2013,4,30]]}}}